Inactive Instrument
Abpro Corporation Stock Nasdaq
Stocks
US0008501076
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 1.34M 1.16M 1.09M 999K 1.88M 128M 1.91M 12.75M 5M 63.97M 5.05M 4.94M 212M | P/E 2024 |
-2.41x | P/E 2025 | -3.27x |
|---|---|---|---|---|---|
| Enterprise Value | 1.42M 1.23M 1.15M 1.06M 2M 136M 2.02M 13.51M 5.3M 67.78M 5.35M 5.23M 225M | EV / Sales 2024 |
497x | EV / Sales 2025 | - |
| Free-Float |
83.91% | Yield 2024 * |
-
| Yield 2025 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 1.34M | ||
| +0.90% | +0.21% | -0.74% | +13.87% | 48B | ||
| +1.98% | +7.31% | +430.66% | +532.17% | 41.13B | ||
| +3.44% | -2.84% | +29.17% | +8.81% | 37.56B | ||
| +1.40% | -0.89% | +7.63% | +61.93% | 35.91B | ||
| +2.42% | +7.27% | +14.90% | +44.79% | 29.86B | ||
| -0.16% | -4.02% | - | - | 16.12B | ||
| +2.20% | +2.94% | +35.92% | +127.15% | 16.05B | ||
| +1.25% | +1.69% | +4.72% | +18.26% | 13.76B | ||
| +4.25% | -9.28% | -0.78% | -35.46% | 12.1B | ||
| Average | +1.77% | -2.15% | +65.18% | +96.44% | 27.83B | |
| Weighted average by Cap. | +1.91% | -1.29% | +85.86% | +120.78% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 183K 158K 148K 136K 256K 17.4M 259K 1.74M 680K 8.7M 687K 672K 28.86M | - |
| Net income | -7.23M -6.26M -5.84M -5.37M -10.13M -688M -10.25M -68.57M -26.89M -344M -27.16M -26.56M -1.14B | -2.89M -2.5M -2.33M -2.15M -4.05M -275M -4.1M -27.42M -10.75M -138M -10.86M -10.62M -456M |
| Net Debt | 478K 414K 386K 355K 670K 45.46M 677K 4.53M 1.78M 22.74M 1.8M 1.76M 75.38M | 80K 69.24K 64.56K 59.41K 112K 7.61M 113K 759K 297K 3.81M 300K 294K 12.62M |
Employees
-
















